These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 14970591)

  • 1. AAV vector delivery to cells in culture.
    Smith A; Collaco R; Trempe JP
    Methods Mol Biol; 2004; 246():167-77. PubMed ID: 14970591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors.
    Shi W; Arnold GS; Bartlett JS
    Hum Gene Ther; 2001 Sep; 12(14):1697-711. PubMed ID: 11560765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of robust immune responses against human immunodeficiency virus is supported by the inherent tropism of adeno-associated virus type 5 for dendritic cells.
    Xin KQ; Mizukami H; Urabe M; Toda Y; Shinoda K; Yoshida A; Oomura K; Kojima Y; Ichino M; Klinman D; Ozawa K; Okuda K
    J Virol; 2006 Dec; 80(24):11899-910. PubMed ID: 17005662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RGD inclusion in VP3 provides adeno-associated virus type 2 (AAV2)-based vectors with a heparan sulfate-independent cell entry mechanism.
    Shi W; Bartlett JS
    Mol Ther; 2003 Apr; 7(4):515-25. PubMed ID: 12727115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity.
    Rabinowitz JE; Rolling F; Li C; Conrath H; Xiao W; Xiao X; Samulski RJ
    J Virol; 2002 Jan; 76(2):791-801. PubMed ID: 11752169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adeno-associated virus (AAV) serotypes 2, 4 and 5 display similar transduction profiles and penetrate solid tumor tissue in models of human glioma.
    Thorsen F; Afione S; Huszthy PC; Tysnes BB; Svendsen A; Bjerkvig R; Kotin RM; Lønning PE; Hoover F
    J Gene Med; 2006 Sep; 8(9):1131-40. PubMed ID: 16810631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insertional mutagenesis at positions 520 and 584 of adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors with eliminated heparin- binding ability and introduced novel tropism.
    Shi X; Fang G; Shi W; Bartlett JS
    Hum Gene Ther; 2006 Mar; 17(3):353-61. PubMed ID: 16544984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conjugate-based targeting of recombinant adeno-associated virus type 2 vectors by using avidin-linked ligands.
    Ponnazhagan S; Mahendra G; Kumar S; Thompson JA; Castillas M
    J Virol; 2002 Dec; 76(24):12900-7. PubMed ID: 12438615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells.
    Nicklin SA; Buening H; Dishart KL; de Alwis M; Girod A; Hacker U; Thrasher AJ; Ali RR; Hallek M; Baker AH
    Mol Ther; 2001 Sep; 4(3):174-81. PubMed ID: 11545607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Adeno-Associated Virus Serotype Tropism in Human Retinal Explants.
    Wiley LA; Burnight ER; Kaalberg EE; Jiao C; Riker MJ; Halder JA; Luse MA; Han IC; Russell SR; Sohn EH; Stone EM; Tucker BA; Mullins RF
    Hum Gene Ther; 2018 Apr; 29(4):424-436. PubMed ID: 29160116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-γ inducible factor 16 (IFI16) restricts adeno-associated virus type 2 (AAV2) transduction in an immune-modulatory independent way.
    Sutter SO; Tobler K; Seyffert M; Lkharrazi A; Zöllig J; Schraner EM; Vogt B; Büning H; Fraefel C
    J Virol; 2024 Jul; 98(7):e0011024. PubMed ID: 38837381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New recombinant serotypes of AAV vectors.
    Gao G; Vandenberghe LH; Wilson JM
    Curr Gene Ther; 2005 Jun; 5(3):285-97. PubMed ID: 15975006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adeno-associated virus vectors serotyped with AAV8 capsid are more efficient than AAV-1 or -2 serotypes for widespread gene delivery to the neonatal mouse brain.
    Broekman ML; Comer LA; Hyman BT; Sena-Esteves M
    Neuroscience; 2006; 138(2):501-10. PubMed ID: 16414198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism.
    Wu P; Xiao W; Conlon T; Hughes J; Agbandje-McKenna M; Ferkol T; Flotte T; Muzyczka N
    J Virol; 2000 Sep; 74(18):8635-47. PubMed ID: 10954565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoring the natural tropism of AAV2 vectors for human liver.
    Cabanes-Creus M; Hallwirth CV; Westhaus A; Ng BH; Liao SHY; Zhu E; Navarro RG; Baltazar G; Drouyer M; Scott S; Logan GJ; Santilli G; Bennett A; Ginn SL; McCaughan G; Thrasher AJ; Agbandje-McKenna M; Alexander IE; Lisowski L
    Sci Transl Med; 2020 Sep; 12(560):. PubMed ID: 32908003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herpes simplex virus type 1/adeno-associated virus rep(+) hybrid amplicon vector improves the stability of transgene expression in human cells by site-specific integration.
    Wang Y; Camp SM; Niwano M; Shen X; Bakowska JC; Breakefield XO; Allen PD
    J Virol; 2002 Jul; 76(14):7150-62. PubMed ID: 12072515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adeno-associated virus serotypes 1 to 5 mediated tumor cell directed gene transfer and improvement of transduction efficiency.
    Hacker UT; Wingenfeld L; Kofler DM; Schuhmann NK; Lutz S; Herold T; King SB; Gerner FM; Perabo L; Rabinowitz J; McCarty DM; Samulski RJ; Hallek M; Büning H
    J Gene Med; 2005 Nov; 7(11):1429-38. PubMed ID: 15945124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement is an essential component of the immune response to adeno-associated virus vectors.
    Zaiss AK; Cotter MJ; White LR; Clark SA; Wong NC; Holers VM; Bartlett JS; Muruve DA
    J Virol; 2008 Mar; 82(6):2727-40. PubMed ID: 18199646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-EpCAM-conjugated adeno-associated virus serotype 2 for systemic delivery of EGFR shRNA: Its retargeting and antitumor effects on OVCAR3 ovarian cancer in vivo.
    Lee S; Ahn HJ
    Acta Biomater; 2019 Jun; 91():258-269. PubMed ID: 31026519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adeno-associated virus mediated gene transfer into lung cancer cells promoting CD40 ligand-based immunotherapy.
    Wu JQ; Zhao WH; Li Y; Zhu B; Yin KS
    Virology; 2007 Nov; 368(2):309-16. PubMed ID: 17675129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.